Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial

L. Kristin Newby, Michael S. Marber, Chiara Melloni, Lea Sarov-Blat, Laura H. Aberle, Philip E. Aylward, Gengqian Cai, Robbert J. De Winter, Christian W. Hamm, John F. Heitner, Raymond Kim, Amir Lerman, Manesh R. Patel, Jean Francois Tanguay, John J. Lepore, Hussein R. Al-Khalidi, Dennis L. Sprecher, Christopher B.I. Granger

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Fingerprint Dive into the research topics of 'Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences